Pharma is betting big on connecting potential patients to its medications. It's just the beginning
Pharma companies are getting more serious about telehealth.
In the past three months, Eli Lilly launched a splashy website connecting consumers with places to get prescriptions for obesity, diabetes and migraine medications, AstraZeneca made its first virtual option for asthma patients and Phathom introduced a telehealth feature when launching its acid blocker marketing campaign.
Industry experts anticipate that offering consumers a direct way to reach prescriptions will become part of the future of drug marketing and commercialization. Consumers want to get prescription healthcare the way they get many other products — fast, easy and online. And there’s potential for broader access to medicines for remote patients.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.